Document is current

Any future updates will be listed below

Lifestyle risks exposure and response predictor of gefitinib in patients with non-small cell lung cancer

Crossref DOI link: https://doi.org/10.1007/s12032-014-0220-4

Published Online: 2014-09-13

Published Print: 2014-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark